Modeling CAR T-cell therapy with patient preconditioning
From MaRDI portal
Publication:2662113
DOI10.1007/s11538-021-00869-5zbMath1460.92099OpenAlexW3036871228MaRDI QIDQ2662113
Publication date: 8 April 2021
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1101/2020.06.20.162925
preconditioningODE modeltumor-immune interactioncombination treatmentchimeric antigen receptor T-cells
Related Items (2)
Can the Kuznetsov model replicate and predict cancer growth in humans? ⋮ A combination therapy of oncolytic viruses and chimeric antigen receptor T cells: a mathematical model proof-of-concept
Cites Work
- B cell chronic lymphocytic leukemia - a model with immune response
- Modeling immunotherapy of the tumor -- immune interaction
- Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
- Some mathematical models for cancer chemotherapy
- A chemotherapy model for the treatment of cancer with metastasis
- Ordinary differential equation models for adoptive immunotherapy
- Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations
- Interactions between the immune system and cancer: A brief review of non-spatial mathematical models
- Introduction to Applied Nonlinear Dynamical Systems and Chaos
This page was built for publication: Modeling CAR T-cell therapy with patient preconditioning
